ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 18 of 28 for:    "craniosynostoses" OR "muenke syndrome"

Optic Nerve Sheath Diameter in Craniosynostosis (ONSD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03131245
Recruitment Status : Completed
First Posted : April 27, 2017
Last Update Posted : October 15, 2018
Sponsor:
Information provided by (Responsible Party):
Hee-Soo Kim, Seoul National University Hospital

Brief Summary:
Changes of optic nerve sheath diameter after position changes

Condition or disease
Optic Nerve Sheath Diameter

Detailed Description:
Changes of optic nerve sheath diameter after position changes from supine to prone position in children for craniosynostosis

Study Type : Observational
Actual Enrollment : 30 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Changes of Optic Nerve Sheath Diameter in Modified Prone Position in Craniosynostosis Children
Actual Study Start Date : June 23, 2017
Actual Primary Completion Date : June 17, 2018
Actual Study Completion Date : July 31, 2018





Primary Outcome Measures :
  1. optic nerve sheath diameter [ Time Frame: 10 minutes after prone position ]
    optic nerve sheath diameter measure with ultrasound



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
children for correction of craniosyostosis
Criteria

Inclusion Criteria:

  • craniosynostosis

Exclusion Criteria:

  • infection on eye area

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03131245


Locations
Korea, Republic of
SNUH
Seoul, Jongro Gu, Korea, Republic of, 15710
Sponsors and Collaborators
Seoul National University Hospital

Responsible Party: Hee-Soo Kim, MD, PhD, Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT03131245     History of Changes
Other Study ID Numbers: H1703-147-840
First Posted: April 27, 2017    Key Record Dates
Last Update Posted: October 15, 2018
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Craniosynostoses
Synostosis
Dysostoses
Bone Diseases, Developmental
Bone Diseases
Musculoskeletal Diseases
Craniofacial Abnormalities
Musculoskeletal Abnormalities
Congenital Abnormalities